However, deal volume slipped somewhat during the same period, with a 16 percent decrease in transactions from the fourth quarter of 2010 and an 8 percent dip from the year-ago quarter.
Pharmaceutical M&A spending totaled $13.5 billion for the quarter, representing 24 percent of all healthcare M&A spending, and medical device M&A totaled $11.7 billion, or 21 percent of spending. Hospital M&A totaled $1.9 billion, or 4 percent of spending. M&A activity spending for physician medical groups was $14.6 million, less than 1 percent of spending.
By deal volume, long-term care ranked first among subsectors with 27 deals. Hospitals completed 23 deals, up 156 percent from 9 deals in the first quarter of 2010 but down 4 percent from the fourth quarter of 2010 (24 deals). Physician groups were involved in 12 deals, up 50 percent from a year ago.
Read the release on Irving Levin’s “The Health Care M&A Report“.
Read more coverage on healthcare M&A:
– Hospital M&A Continued to Grow in Second Half of 2010
– The Biggest Players in 2010 Healthcare M&A
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
